Eton Pharmaceuticals (ETON) EBT (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of EBT data on file, last reported at $1.4 million in Q4 2025.

• For the quarter ending Q4 2025, EBT rose 376.71% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at -$4.6 million (down 19.7% YoY), and the FY2025 full-year result was -$4.6 million, down 19.7% from the prior year.
• EBT climbed to $1.4 million in Q4 2025, from -$2.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $5.1 million in Q1 2021 to a low of -$6.1 million in Q3 2021.
• A 5-year average of -$1.0 million and a median of -$1.5 million in 2022 frame the typical range for EBT.
• Across the five-year window, EBT jumped 392.62% in 2023 and sank 490.22% in 2025, its largest moves.
• Tracing ETON's EBT over 5 years: stood at $1.0 million in 2021, then dropped by 12.22% to $912000.0 in 2022, then tumbled by 320.29% to -$2.0 million in 2023, then soared by 74.56% to -$511000.0 in 2024, then soared by 376.71% to $1.4 million in 2025.
• Business Quant data shows ETON's EBT at $1.4 million in Q4 2025, -$2.0 million in Q3 2025, and -$2.5 million in Q2 2025.